ClosedPublished 13 May 2022

Medtronic /
Intersect ENT

Medtronic adds Intersect ENT’s sinus implant products

Terms
Not stated
Stage
Closed
Source · 13 May 2022
01 / BuyerMedtronic
02 / TargetIntersect ENT
01

What happened

Medtronic plc completed its acquisition of Intersect ENT, adding the PROPEL and SINUVA sinus implant product lines, technology, intellectual property and facility to its portfolio.

Intersect ENT employees joined Medtronic through the acquisition. Each share of Intersect ENT common stock converted into the right to receive $28.25 in cash.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Medtronic adds Intersect ENT’s sinus implant products

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.